Petco Health and Wellness Company, Inc. WOOF
2.27
(0.02)
(0.87%)
as of 25 Sep
- Market cap
- $641.6M
- P/E
- 20.6×
Follow WOOF
| Jul '26 | Apr '26 | Jan '26 | Oct '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
25.36 | 142.00 | 90.67 | 0.00 |
+8 more quarters Free account |
P/S ratio |
0.13 | 0.14 | 0.13 | 0.15 | |
P/FCF ratio |
3.35 | 4.94 | 4.01 | 6.74 | |
P/Operating CF |
4.93 | (26.02) | 4.95 | 9.90 | |
P/B ratio |
0.66 | 0.70 | 0.65 | 0.77 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
0.33 | 0.35 | 0.33 | 0.37 | |
EV/EBITDA |
5.90 | 6.42 | 6.20 | 7.04 | |
EV/Operating CF |
5.29 | 7.09 | 6.36 | 8.74 | |
EV/FCF |
8.32 | 12.99 | 10.54 | 16.94 | |
Quick Ratio |
0.28 | 0.18 | 0.27 | 0.25 | |
Current Ratio |
0.90 | 0.85 | 0.90 | 0.91 | |
Net Debt/EBITDA |
11.87 | 17.48 | 15.20 | 16.92 | |
Debt/Assets |
28.56% | 29.06% | 28.86% | 30.49% | |
Debt/Equity |
1.22 | 1.28 | 1.28 | 1.37 | |
Asset Turnover |
1.16 | 1.17 | 1.15 | 1.15 | |
Operating CF/Net income |
4.18 | 2.04 | (59.62) | 9.66 | |
Capex/Depreciation |
(0.61) | (0.76) | (0.75) | (0.58) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
36.48% | 36.73% | 36.23% | 36.86% | |
Intangible Assets out of Total Assets |
0.39 | 0.39 | 0.39 | 0.39 | |
Share Based Compensation of Revenue |
0.58% | 0.63% | 0.48% | 0.49% | |
Graham Net Nets |
(3.65) | (3.68) | (3.93) | (3.41) | |
Graham Number |
3.23 | 1.35 | 1.68 | 0.00 | |
Earnings Yield |
3.94% | 0.70% | 1.10% | (0.31%) | |
Free Cash Flow Yield |
29.86% | 20.23% | 24.92% | 14.83% | |
Revenue per Share |
5.21 | 5.28 | 5.42 | 5.22 | |
Operating CF per Share |
0.57 | (0.11) | 0.55 | 0.32 | |
Capex per Share |
(0.11) | (0.13) | (0.13) | (0.10) | |
Free Cash Flow per Share |
0.45 | (0.24) | 0.42 | 0.22 | |
Cash per Share |
1.03 | 0.59 | 0.92 | 0.85 | |
Shareholders Equity per Share |
4.23 | 4.07 | 4.16 | 4.13 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
4.23 | 4.07 | 4.16 | 4.13 | |
Free Cash Flow |
129.92 | (69.12) | 116.39 | 60.76 | |
Working Capital |
(113.35) | (169.42) | (114.35) | (96.06) | |
Capital Expenditures |
(31.63) | (38.15) | (37.14) | (29.33) | |
Net Current Asset Value |
(2,906.62) | (2,968.44) | (2,989.38) | (3,040.13) | |
EV/EBIT |
14.82 | 16.44 | 16.58 | 21.15 | |
Capex to Sales |
0.02 | 0.03 | 0.02 | 0.02 | |
Net Profit Margin |
2.60% | (1.01%) | (0.17%) | 0.64% | |
Price to Operating Income |
5.97 | 6.26 | 6.31 | 8.41 | |
| Other line items | |||||
Average Receivables |
36.46 | 36.50 | 43.12 | 41.67 | |
Average Payables |
439.29 | 477.28 | 471.72 | 438.83 | |
Average Inventory |
605.05 | 639.19 | 621.77 | 654.09 | |
Average Assets |
5,159.97 | 5,102.86 | 5,183.93 | 5,208.30 | |
Average Common Equity |
1,173.02 | 1,131.32 | 1,138.94 | 1,140.22 |
Columns are period end dates